Allergy/Asthma News

NEW ORLEANS — Adults with asthma and hypogonadism have greatly increased risk for mortality during hospitalization compared with adults with asthma and normal testosterone levels, according to data presented at the AACE annual meeting.

Pollen predictions on public websites across five U.S. cities showed significant inaccuracies, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Luz S. Fonacier, MD, FACAAI, FAAAAI, has shattered multiple glass ceilings in her career as an allergist.

Rural unincorporated colonias in the U.S.-Mexico borderlands have limited access to health care, showing that geography is a determinant of health in low-income communities, according to a study published in Social Science & Medicine.

A $22 million award from the Patient-Centered Outcomes Research Institute will support a study comparing the effectiveness of two strategies for asthma treatment.

Ruxolitinib cream 1.5% was safe and well tolerated up for the short- and long-term treatment of atopic dermatitis in adolescents, according to an analysis of two phase 3 studies.

Since there is so much going on in food allergy studies and care — and so much more that needs to be done — the Center for Food Allergy & Asthma Research is having three simultaneous conferences this summer, and everyone is invited.

Galderma has received filing acceptances for nemolizumab for the treatment of prurigo nodularis and atopic dermatitis in Australia, Singapore, Switzerland and the United Kingdom, the company announced in a press release.

Usually when people are allergic to something, the protein causes the allergy. Contrary to myth, sugars typically do not cause allergic reactions. Rather, they can contribute to different issues such as food intolerances and sensitivities.

Asthma is a disease that affects over 25 million people in the U.S. alone, with a consistently rising prevalence that experts say is exacerbated by changing climates and substantial health care costs.